STOCK TITAN

Precipio Inc - PRPO STOCK NEWS

Welcome to our dedicated news page for Precipio (Ticker: PRPO), a resource for investors and traders seeking the latest updates and insights on Precipio.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Precipio's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Precipio's position in the market.

Rhea-AI Summary
Specialty cancer diagnostics company Precipio, Inc. has announced a registered direct offering and concurrent private placement of common stock and warrants. The offering consists of 4,125,000 shares of common stock, pre-funded warrants to purchase 319,445 shares, and warrants to purchase up to 8,888,890 shares at a combined purchase price of $0.45. The net proceeds are expected to be approximately $2 million, which will be used for working capital and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.41%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.25%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.75%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.71%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.71%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.39%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.91%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
none
Precipio Inc

Nasdaq:PRPO

PRPO Rankings

PRPO Stock Data

9.52M
1.39M
3.66%
10.38%
0.37%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Omaha

About PRPO

precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. our goal is to assist oncologists in providing the best care for their patients. at the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the yale school of medicine. at precipio, our customers and their patients benefit from the most accurate, expert diagnosis. we provide our customers exclusive access to some of the most innovative tests in the field of molecular diagnostics, developed through cutting edge research, and the ongoing pursuit and refinement of the science of personalized medicine.